Lobbying client
EUROAPI
Contract Development and Manufacturing Organization; Manufacture of small molecule APIs
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$210,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2023 to 2024
Filings
2 filings for 2024, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2024
|
AKIN GUMP STRAUSS HAUER & FELD | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2024
|
AKIN GUMP STRAUSS HAUER & FELD | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| AKIN GUMP STRAUSS HAUER & FELD | 6 | $210,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Manufacturing | MAN | 5 |
| Health Issues | HCR | 5 |
| Pharmacy | PHA | 5 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.